We examine the demand for private health insurance (PHI) in the United Kingdom and relate this to changes in the supply of public and private healthcare. Using a novel collection of administrative, private sector and survey data, we re-assess the relationships between the quality and availability of public and private sector inpatient care, and the demand for PHI. We find that PHI coverage in the United Kingdom is positively related to the median of the region-and year-specific public sector waiting times. We find that PHI prevalence ceteris paribus increases with being self-employed and employed, while it decreases with having financial difficulties. In addition, we highlight the complexities of inter-sectoral relations and their impact on PHI demand. Within a region, we find that an increase in private healthcare supply is associated with a decrease in public sector waiting times, implying lower PHI demand. This may be explained by the usage of private facilities by NHS commissioners. These results have important implications for policymakers interested in the role of private healthcare supply in enhancing the availability of and equitable access to acute inpatient care.
INTRODUCTION
This paper examines the determinants of demand for private health insurance (PHI) in the United Kingdom -a context in which the National Health Service (NHS) provides a comprehensive statutory package of services free-at-the-point-of-use, and in which supplementary coverage is held by approximately 15% of the population aged over 20. This coverage offers insurance against the costs of privately-delivered services that are also provided within the NHS (for which PHI subscribers must continue to pay through their taxes and to which they retain full access). The key attractions of holding such coverage are therefore the access to faster treatment and wider choice of specialists, facilities and timing of treatment that it may provide (Rodríguez and Stoyanova, 2004) . However, premiums for individual purchasers tend to be expensive, and only a minority of employers offer coverage to their staff (Foubister et al., 2006) . Accordingly, baseline models view the perceived quality of public sector provision, together with income, as the main determinants of the demand for PHI (e.g. Besley et al., 1999; Costa and García, 2003) .
To date, conflicting results have been observed with respect to the association between PHI demand and the quality of NHS services, as measured by waiting times. 1 Besley et al. (1999) find that regions of England characterised by longer waiting lists have higher PHI coverage on average. King and Mossialos (2005) also find significant associations between waiting times and PHI coverage. In contrast, Propper et al. (2001) find that, in England, waiting lists do not play a role in explaining PHI coverage. Instead, the number of private hospitals and senior doctors are important, along with age. The authors suggest that as the stock of medical labour is fixed in the short run higher private sector capacity reduces the supply of senior doctors available to the NHS, giving rise to a perception among patients that the quality and capacity of the private sector has increased relative to those of the NHS.
Overall, the evidence suggests that perceived differences in quality and capacity between the public and private sectors have a major influence on PHI demand. However, the latter study draws attention to the complex nature of public-private sector interaction in terms of the effect on demand for PHI. In this respect, it is significant that the extent of such interaction has increased since these earlier studies were conducted. This is especially the case in England where market-oriented structural reforms aimed at providing patients with more choice have been an important part of the policy framework.
Since 2002, many NHS patients (in England and to a lesser extent in Scotland and Wales) have been treated at private hospitals for diagnostic and elective services. From January 2006, General Practitioners were required to offer patients a choice of four or five hospitals (Naylor and Gregory, 2009 ). In addition, reforms introduced between 2003 and 2008 formalised and greatly increased the ability of private hospitals to compete with NHS hospitals for patients, for instance through the so-called Independent Sector Treatment Centre programme, which delivered a wide range of routine elective care for NHS-funded patients (Kelly and Stoye, 2015) . In consequence, spending on private facilities by NHS commissioners in England (mostly Primary Care Trusts and, from 2011, some Clinical Commissioning Groups) more than quadrupled in real terms between 2002 and 2012, to £1.2 billion (Competition & Markets Authority, 2014) . By the end of that period funding from NHS commissioners constituted 28% of inpatient income for private hospitals (Laing & Buisson, 2013) .
In this context, the relationships between the supply of private healthcare and the demand for PHI has become more complex than was the case when the aforementioned studies were undertaken. For instance, higher private sector capacity might increase the demand for PHI if inpatient care providers are able to "induce" demand for their services and consumers seek financial protection against the associated costs (Labelle et al., 1994) .
In this case, the positive effect of higher private sector supply on PHI demand may offset the negative effect of lower NHS waiting times on PHI demand. Conversely, if private hospital capacity is made available to NHS patients, and this leads to a reduction in NHS waiting times, this may contribute to a reduction in PHI demand.
Our aim, therefore, is to examine the PHI demand and the relationships with the quality and availability of public and private sector inpatient care. To address this aim, we use a novel combination of survey data from 2000-2011 matched with administrative and private sector data. In addition, we use new waiting time measure. According to Foubister et al. (2006) , PHI packages typically cover surgery as an inpatient or day case, hospital accommodation and nursing care, and inpatient tests. We therefore use a measure of NHS waiting time that is likely to be most relevant to the choice between publicly and privately financed healthcare -the median inpatient waiting time.
The remainder of this paper is structured as follows. In section 2, we outline our data sources and descriptive statistics. In section 3, we present our empirical results. In section 4, we relate our findings to previous theoretical and empirical literature and end with an outline of policy implications.
DATA AND PRELIMINARY ANALYSIS
We make use of data from two surveys covering the period 2000-2011: the British Household Panel Survey (BHPS) and the English Longitudinal Study of Ageing (ELSA). Both the BHPS and ELSA data were accessed through the UK Data Archive (UKDA). The BHPS ran annually between 1990 and 2008 but the questions regarding PHI coverage were only asked from wave 6 (1996). After 2008 the Understanding Society survey replaced the BHPS, but does not provide information on PHI coverage. In our analysis of the BHPS we excluded respondents aged below 20 years and those living in Northern Ireland. We focus on the years 2000-2008 as some of the regional level indicators are not available for earlier years.
ELSA is a bi-annual survey covering people aged 50 and above, restricted to England only.
The first wave of the survey was conducted in 2002/2003, and we use data up to years 2010/2011 (wave 5). Using two different surveys (BHPS and ELSA) allows us to check the robustness of the results with respect to the source of individual data, finding that the results are qualitatively robust. In addition, the ELSA data make it possible to extend the analysis period up to 2011.
We focus on a single indicator of PHI coverage: whether the respondent is covered by any type of PHI, regardless of whether this coverage is provided by an employer or through the purchase of another family member. The prevalence of PHI coverage among the population aged over 20 was 15.4% in 2008, the final year of the BHPS. Of this, around one third paid all or a part of the premium directly; one third received the insurance via their employer; and the final third were insured through the purchase of another family member. Table 1 shows the time pattern of PHI coverage rates in the UK. The coverage rates fell at the end of the 1990s, when tax relief on PHI premiums was discontinued, and again in 2007, which we assume is due to the financial crisis which began in that year. The degree of stability in the PHI rates is notable, given that this was a period in which NHS funding increased at its fastest ever rate, at an average of 6.6% per year between 2000 and 2008 (Appleby et al., 2008) , which might have been expected to exert greater influence on PHI coverage rates. This may imply that the high transaction costs associated with buying and selling PHI, alongside a certain degree of consumer inertia, were features of this market in this period. In addition, , as we discuss below, factors such as lower waiting times and the higher supply of private care may have offsetting effects.
According to the BHPS data, PHI coverage is most prevalent among people aged30-60, and the coverage rate peaks around age 40. The difference between the BHPS and ELSA statistics, which can also be seen in Table 1 , are explained by the different age coverage.
Coverage rates are higher in England than in Scotland and Wales, and there is considerable regional variation in PHI prevalence also within England. The highest prevalence is observed in London, the East of England and the South East. ***[insert Table 1 Table 1 ). We use various public data sources to construct the indicators of public inpatient healthcare availability. We do not use indicators of the availability of outpatient care. Since PHI typically covers inpatient care only, it is unlikely that outpatient care availability would exert a strong influence on PHI demand. Detailed descriptions of the data sources and the construction of the variables are provided in Appendix A. Region-specific statistics at the beginning and end of the study period are provided in Appendix B. (2000) (using Spanish data), in which the length of waiting lists are used as a proxy for waiting times, we collected data on median waiting times. This indicator captures more effectively the time that patients can expect to wait for inpatient treatment, which is more likely to influence PHI demand than the length of waiting lists itself (as also pointed out by Johar et al. (2013) ).
In the first part of the period the median inpatient waiting times increased (by up to approximately seven weeks in England) but then fell from 2005 onwards (down to around five weeks in England). Differences in statistical methodologies across regions and over time imply measurement errors, decreasing the statistical significance of the empirical results.
The BHPS results are robust to restricting the estimation sample to England only, thus avoiding the measurement differences with Scotland and Wales.
The private healthcare data are from Laing and Buisson's Healthcare Market Review, volumes 1999 /2000 through to 2009 /2010 Buisson is an independent specialist consultancy in health and community care, and has reviewed the UK private healthcare market since 1988. The time pattern of private and public inpatient beds per capita is starkly different in two ways. First, the average number of available private beds is an order of magnitude smaller than of the public beds (three NHS hospital beds and 0.35 private inpatient beds per 1000 inhabitants in England in 2010/2011). Second, the trend of available private beds is increasing, while the number of public beds has diminished. This contrast is particularly notable in Wales, which has seen both the strongest increase in private beds and the strongest decrease in public beds.
EMPIRICAL RESULTS
In section 3.1, we analyse how PHI is related to the quality and availability of public healthcare services and the availability of private healthcare services. In section 3.2, we document the interrelations between the supply of private inpatient care services, and the quality and availability of public inpatient care services. In section 3.3, we extend the analysis of PHI coverage with indicators of NHS spending on private care and private care quality. We summarise the results in section 3.4.
Identifying the determinants of PHI coverage
First, we estimate probit models of PHI coverage to reveal the correlations with health care indicators. The estimated model is:
Subscript i refers to individual, r to region, and t to time. Next, we extend the model with year effects and individual fixed effects (FE) and estimate a linear probability FE model. We apply this linear specification to avoid the problem of incidental parameters inherent in probit FE models:
In the above, ̃ is the same as in equation (1) In columns (1) and (2) of Table 2 we present the estimates based on the BHPS data, and in columns (3) and (4) we present the results based on the ELSA data. Subjective health is excluded from the set of regressors when using the ELSA data, because it is unavailable for wave 3. Also, we do not include indicators of political preferences because of the lack of variables comparable to the BHPS indicators.
***[insert Table 2 about here]***
Estimating equation (1) shows a positive correlation of PHI coverage with NHS waiting times, and a negative correlation with public healthcare expenditures. These relations are statistically significant and of the expected sign, as higher quality and availability of public healthcare decreases the demand for care that is not funded by the NHS, and hence also for PHI. The positive relation to waiting times is stronger in the ELSA data, which is based on later years and an older population. In addition, PHI coverage is more likely to be purchased if there is a greater supply of private care in the region. The relation to the relative number of public hospital beds is insignificant.
Further analysis of the results of columns (1) and (3) The estimated coefficient of private inpatient care supply has an unexpected negative sign when equation (2) is estimated using the BHPS data, implying that an increase in private supply within a region is on average negatively related to PHI coverage.
One possible explanation is that the increasing degree of competition among private providers (that is implied by greater capacity) drives down the costs of service provision, thereby lowering the demand for PHI. However, in the context of a recent inquiry by the UK Competition and Markets Authority (2014), which found high barriers to entry and expansion for private hospitals and weak competition among private hospitals in many markets, this explanation is unpersuasive. A more likely explanation is that a higher number of private beds enables greater usage of private hospitals by the NHS in order to reduce waiting times, thereby reducing PHI demand. This explanation is further supported by the results on private beds and waiting times reported in section 3.2 below.
The results also indicate that, over the analysed years, there was very little variation in PHI coverage within each region, and hence little change to be explained by regionspecific variation in the indicators of public and private care. The significant relations between PHI coverage and public and private healthcare indicators stem from aggregate, not region-specific, changes in supply and from time-invariant differences in PHI demand and the supply of healthcare across regions.
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The results of equation (2) 
where index indicates region and index time. We run three separate regressions: first, waiting times; second, public hospital beds; third, public health expenditures included as regressor. This is essentially a correlation analysis among the variables cleaned from the region-specific, time-invariant characteristics. The estimated 1 coefficients are presented in 
Extensions with further indicators of private care
In section 3.1. above, we showed that across regions, the number of private inpatient beds is positively related to PHI demand. To analyse how the use of private beds by the NHS and the quality of private inpatient care influence this relationship, we re-estimate equation (1) with additional indicators. As we have observations for a few waves only, we cannot reliably re-estimate equation (2), and do not include these indicators as part of the main specifications. For the purpose of simplifying the discussion, we estimate these models on the BHPS data, only. The detailed results are reported in Appendix C. Next, as a proxy for the quality of private inpatient care, we use the regional level median prices of two treatment types: hip replacement (median price: £11,054) and cataract surgery (median price: £2,420). These indicators are based on the prices quoted in "privatehealth.co.uk" website (Appendix A provides further details). The rationale for using price as a proxy for quality is based on Bagwell and Riordan (1991) and Wolinsky (1983) , who show that high prices are an efficient means of signalling quality where information is asymmetric between producers and consumers (which is likely to be the case for inpatient care). As historical data are unavailable, we have to make the assumption that regional differences in private care quality are permanent.
Re-estimating equation (1) these results provide weak evidence that the demand for PHI increases with the regional level quality of private inpatient care.
Summary of results
In relation to the first part of the analysis (section 3.1), we conclude that longer waiting times are associated with higher PHI prevalence. Specifically, an increase in median inpatient waiting times of 10 weeks is associated with a 2-8 percentage points higher rate of PHI coverage. This positive relationship can be seen if we analyse PHI coverage differences both within regions through time and across regions. In terms of the latter, there is a positive association between higher PHI coverage and the supply of private healthcare.
Increasing the number of private inpatient beds by one per 1000 inhabitants is associated with approximately 23-29 percentage points higher PHI prevalence. Across regions, we find positive relationships between private sector capacity, PHI coverage and waiting times. The availability of NHS hospital beds has a weaker relation to PHI coverage probability. and survey data, we find that PHI coverage is positively related to NHS waiting times, employment, and financial status. The results on waiting times correspond to the predictions of the models presented by Besley et al. (1999) and Costa and García (2003) among others. They are consistent with the findings of previous empirical studies (Besley et al. 1999; King and Mossialos, 2005) , but contrary to those of Propper et al. (2001) . The results are based on region and time specific median inpatient waiting times, which capture more effectively the time that patients can expect to wait for hospital admission than mean waiting times, or the length of the waiting lists.
The period we examine is one in which the role of the private sector in the delivery of publicly funded health services has increased against a backdrop of rising real expenditures, decreasing numbers of NHS inpatient beds, increasing numbers of private sector inpatient beds, and falling NHS waiting times. Our findings highlight the complexity of intersectoral interactions in this context. Within a region over time an increase in private inpatient healthcare supply is associated with a decrease in waiting times and PHI prevalence. This may be explained by the purchase of private care by NHS commissioners, reducing waiting times and the propensity of consumers to buy PHI. This suggests that greater use of private sector by the NHS can help to cut waiting times and reduce PHI demand. This interpretation is supported by Kelly and Stoye (2015) , who show that the introduction of privately owned hospitals in geographic areas increased overall demand for elective hip replacements but also reduced waiting times for these services in those areas.
However, it is worth noting that large-scale use of private sector capacity in recent years has been enabled by historic increases in public expenditure on healthcare which are unlikely to re-occur in the coming years (NHS England, 2013). Our results have implications for policymakers that operate in a context of tight budgetary control. The current NHS England planning framework, for example, assumes that NHS expenditure will grow at approximately the rate of inflation between 2010/11 and 2020/21, with the result that expenditure as a proportion of GDP will decrease from 7.7% to 6% (NHS England, 2013).
These projections are likely to imply stricter control, and perhaps more rationing, of publicly funded health services. In this respect, the positive relationship between the availability of private inpatient healthcare, waiting times and PHI coverage across regions is likely to be of interest to policy-makers. The results imply that higher waiting times result in higher demand for private inpatient care, and financial protection against the associated costs.
In this context, our results suggest that the demand for PHI may increase in the coming years as publicly financed care (undertaken in both the public and the private sector) is constrained. In addition, we have shown that the prevalence of PHI coverage increases with being self-employed and employed and with deteriorating health, and decreases with having financial difficulties. It is possible that a change in the propensity to use privately-financed healthcare, especially among the relatively affluent, may in the coming years erode support for the NHS and/or enhance the political acceptability of alternatives which, in turn, may lead to greater inequity in coverage and access to healthcare. (1) and (3): gender, age, secondary and higher education dummy, having children. Robust standard errors in brackets, ***p<0.01, ** p<0.05, * p<0.1. Region fixed effects included. Each column corresponds to a separate regression. 
